Oct 1, 2021 For Immediate Release – Fibrocor Therapeutics Inc, a precision medicine company developing first in class drugs for IPF and other fibrotic diseases, is participating at the upcoming Piper Sandler Lung Day conference on October 15, 2021 at 11:30 am ET. The format will be a fireside discussion amongst investors, analysts and KOLs in the field regarding the progression of new medicines for the treatment of pulmonary diseases.
MEDIA RELATIONS
Julie A. Fotheringham
Partner, HAGEMAN Communications
Julie.fotheringham@hageman.ca
416.951.7988